adagrasib,Pembrolizumab
mirati,merck
['pembro', 'mrtx849', 'krystal-7', 'nsclc', 'ca,022,i', 'sclc', 'adagrasib']
krystal-7: 1l adagrasib + pembrolizumab in #kras g12c had rr 49%, dcr 89% with a very impressive waterfall plot. in pdl1 high, rr 59% (13/22) and in pdl1 low, rr 48% (10/21). for pdl1 negative, 3/10 responses. ttr 1.4m and 66% still on therapy. #esmoimmuno22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Host Official @IASLC Podcast #LCSM #HereWeGo #ITYSL